Funds holding DOGWOOD THERAPEUTICS INC
ISIN US92829J2033 · United States
- Fund holders
- 5
- Of which ETFs
- 0 5 other funds
- Value held
- 324.3K $
- Share of capital
- 0.4 % of 34M shares on Aug 13, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 132,154 | 278.8K $ | 0.00 % | 0.39 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 10,187 | 29K $ | 0.00 % | 0.03 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 2,581 | 7.4K $ | 0.01 % | as of Feb 28, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 2,294 | 6.5K $ | 0.01 % | as of Feb 28, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 880 | 2.5K $ | 0.00 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 5 | 0 | 148,096 | +358.3 % |
| 2026Q1 | 5 | 0 | 32,314 | +2.3 % |
| 2025Q4 | 5 | 0 | 31,592 | +32.5 % |
| 2025Q3 | 5 | 0 | 23,841 | +6.6 % |
| 2025Q2 | 5 | +1 | 22,366 | +113.7 % |
| 2025Q1 | 4 | 10,467 |
Institutional managers
11 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 3,280,000 | 6.9M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 79,434 | 167.6K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 23,779 | 50.2K $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 14,598 | 30.8K $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 11,756 | 24.8K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 8,067 | 17K $ | as of Mar 31, 2026 |
| UBS Group AG | 7,085 | 15K $ | as of Mar 31, 2026 |
| Activest Wealth Management | 120 | 253 $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 30 | 63 $ | as of Mar 31, 2026 |
| GROUP ONE TRADING LLC | 9 | 19 $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 2 | 4 $ | as of Mar 31, 2026 |
Declared shareholders of DOGWOOD THERAPEUTICS INC
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Armistice Capital, LLC and 1 other | 9.99 % | 3,343,120 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding DOGWOOD THERAPEUTICS INC". https://titelia.com/en/stocks/dogwood-therapeutics-inc-US92829J2033